MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52

Yuanbo Li, Yan Sun, Zhenlu Li, Shikuan Li, Changliang Wu

Open source

DOI
10.1155/2022/4033373
Published
2022-02-16
Container
Journal of Healthcare Engineering
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/4033373,
  title = {MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52},
  author = {Yuanbo Li and Yan Sun and Zhenlu Li and Shikuan Li and Changliang Wu},
  year = {2022},
  journal = {Journal of Healthcare Engineering},
  doi = {10.1155/2022/4033373},
  url = {https://doi.org/10.1155/2022/4033373}
}

RIS

TY  - JOUR
TI  - MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
AU  - Yuanbo Li
AU  - Yan Sun
AU  - Zhenlu Li
AU  - Shikuan Li
AU  - Changliang Wu
PY  - 2022
JO  - Journal of Healthcare Engineering
DO  - 10.1155/2022/4033373
UR  - https://doi.org/10.1155/2022/4033373
ER  - 

APA

Li, Y., Sun, Y., Li, Z., Li, S., & Wu, C. (2022). MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52. Journal of Healthcare Engineering. https://doi.org/10.1155/2022/4033373

Source records